BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Northeastern University College of Engineering - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://coe.northeastern.edu
X-WR-CALDESC:Events for Northeastern University College of Engineering
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241104T130000
DTEND;TZID=America/New_York:20241104T150000
DTSTAMP:20260422T222956
CREATED:20241031T135809Z
LAST-MODIFIED:20241031T135809Z
UID:47603-1730725200-1730732400@coe.northeastern.edu
SUMMARY:ChE PhD Dissertation Defense: Rudolf Abdelmessih
DESCRIPTION:Name:\nRudolf Abdelmessih \nTitle: \nInvestigating Strategies for Engineering More Efficient Drug Nanocarriers for Treatment of Human Metastatic Breast Cancer the Impact of Hydrophobic Drug Encapsulation on the Properties of Lipid-Based Nanoparticles and Drug Bioavailability \nDate:\n11/04/2024 \nTime:\n1:00:00 PM \nCommittee Members:\nProf. Debra T. Auguste (Advisor)\nProf. Rebecca Carrier\nProf. Stephen Hatfield\nProf. Francisco Hung\nProf. Benjamin Woolston \nLocation:\nEXP 401-A \nAbstract:\nA significant challenge in cancer treatment is the delivery of water-insoluble\, hydrophobic drugs to tumor tissue at concentrations that are therapeutically effective. One way to address this challenge is by encapsulating hydrophobic drugs into drug delivery systems that would allow them to circulate with blood and diffuse into tumor tissue. Lipid-based nanoparticles (LNPs) constitute most of the drug delivery systems currently approved for clinical use\, owing to their degradability\, lack of toxicity and their wide range of tunable properties. Liposomes are one example of LNPs; they are spherical vesicles comprised of a bilayer phospholipid membrane surrounding an aqueous core\, that can be used to encapsulate hydrophobic drugs. However\, hydrophobic drug encapsulation can change the structure and mechanical properties of the lipid\nmembrane of liposomes\, and the way they interact with cancer cells. Herein\, we investigated the impact of encapsulating different hydrophobic\, anticancer drugs into liposomes on cellular uptake\, tumor accumulation\, gene expression and tumor growth\, in metastatic breast cancer (MBC). \nOur data show that the encapsulation of an LPA receptor antagonist (Ki16425) into liposomes decreased the stiffness of the lipid membrane\, and enhanced their cellular internalization\, and tumor accumulation. Moreover\, we show that the encapsulation of an HDAC inhibitor (NVP) into liposomes increased their cellular uptake\, upregulated the expression of tumor suppressor genes\, and led to a significant cell death in MBC cells. Similarly\, we tested the effect of encapsulating an adenosine receptor antagonist (KW-6002) in a liposomal formulation that can activate cancer-related immune responses. \nIn conclusion\, our results offer insights into the chemical and mechanical behavior of drug-lipid complexes that can impact cellular internalization and tumor delivery\, and may aid in the treatment of MBC.
URL:https://coe.northeastern.edu/event/che-phd-dissertation-defense-rudolf-abdelmessih/
END:VEVENT
END:VCALENDAR